COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,624 Articles (22,913 medRxiv, 8,711 bioRxiv)

Most recent first Previous |  Page 1955: Articles 19541-19550  | Next

Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality
Silva, J., Lucas, C., Sundaram, M., Israelow, B., Wong, P., Klein, J., Tokuyama, M., Lu, P., Venkataraman, A., Liu, F., Mao, T., Oh, J. E., Park, A., Casanovas-Massana, a., Vogels, C. B. F., Muenker, C. M., Zell, J., Fournier, J. B., Campbell, M., Chiorazzi, M., Ruiz Fuentes, E., Yale IMPACT Team, , Grubaugh, N. D., Farhadian, S., Dela Cruz, C., Ko, A., Schulz, W. L., Ring, A. M., Ma, S., Omer, S., Wyllie, A. L., Iwasaki, A.
10.1101/2021.01.04.21249236 — Posted: 2021-01-06
Prevalence and Factors associated with Mental health impact of COVID-19 Pandemic in Bangladesh: A survey-based cross-sectional study
Abir, D. T., Kalimullah, D. N. A., Uchechukwu, D. L. O., Nur -A Yazdani, D. M., Husain, T., Goson, P. C., Basak, P., Rahman, M. A., Al Mamun, D. A., Permarupan, D. P. Y., Khan, M. Y. H., Milton, D. A. H., Agho, D. K.
10.1101/2021.01.05.21249216 — Posted: 2021-01-06
Twitter Discourse on Nicotine as Potential Prophylactic or Therapeutic for COVID-19
Kavuluru, R., Noh, J., Rose, S. W.
10.1101/2021.01.05.21249284 — Posted: 2021-01-06
Genomic epidemiology of the SARS-CoV-2 epidemic in Zimbabwe: Role of international travel and regional migration in spread
Mashe, T., Takawira, F. T., Martins, L. d. O., Gudza-Mugabe, M., Chirenda, J., Munyanyi, M., Gumbo, H., Chaibva, B. V., Nyagupe, C., Tarupiwa, A., Juru, A., Phiri, I., Manangazira, P., Goredema, A., Danda, S., Chabata, I., Jonga, J., Munharira, R., Masunda, K., Mukeredzi, I., Mangwanya, D., The COVID-19 Genomics UK (COG-UK) Consortium, , SARS-CoV-2 Research Group, , Trotter, A., Le Viet, T., Kay, G., Baker, D., Thilliez, G., Gutierrez, A.-V., O Grady, J., Hove, M., Mutapuri-Zinyowera, S., Page, A. J., Kingsley, R. A., Mhlanga, G.
10.1101/2021.01.04.20232520 — Posted: 2021-01-06
Machine Learning Forecast of Growth in COVID-19 Confirmed Infection Cases with Non-Pharmaceutical Interventions and Cultural Dimensions: Algorithm Development and Validation
Yeung, A. Y., Roewer-Despres, F., Rosella, L., Rudzicz, F.
10.1101/2021.01.04.21249235 — Posted: 2021-01-06
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals
Coyle, P. V., Chemaitelly, H., Kacem, M. A. B. H., Al Molawi, N. H. A., El Kahlout, R. A., Gilliani, I., Younes, N., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G. K., Yassine, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Al-Thani, M. H., Bertollini, R., Abu-Raddad, L. J.
10.1101/2021.01.05.21249247 — Posted: 2021-01-06
Associations between Stress and Child Verbal Abuse and Corporal Punishment during the COVID-19 Pandemic and Potential Effect Modification by Lockdown Measures
Jeharsae, R., Jae-noh, M., Jae-a-lee, H., Waeteh, S., Nimu, N., Chewae, C., Yama, M., Dureh, N., Wichaidit, W.
10.1101/2021.01.05.20248973 — Posted: 2021-01-06
Viral Variants and Vaccinations: If We Can Change the COVID-19 Vaccine, Should We?
Bewick, S.
10.1101/2021.01.05.21249255 — Posted: 2021-01-06
Prevalence of RT-PCR-detected SARS-CoV-2 infection at schools: First results from the Austrian School-SARS-CoV-2 Study
Willeit, P., Krause, R., Lamprecht, B., Berghold, A., Hanson, B., Stelzl, E., Stoiber, H., Zuber, J., Heinen, R., Koehler, A., Bernhard, D., Borena, W., Doppler, C., von Laer, D., Schmidt, H., Proell, J., Steinmetz, I., Wagner, M.
10.1101/2021.01.05.20248952 — Posted: 2021-01-06 Discussion: Onsite
Representative Estimates of COVID-19 Infection Fatality Rates from Three Locations in India
Cai, R., Novosad, P., Tandel, V., Asher, S., Malani, A.
10.1101/2021.01.05.21249264 — Posted: 2021-01-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).